These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 34335466)

  • 21. From pancreas morphogenesis to β-cell regeneration.
    Avolio F; Pfeifer A; Courtney M; Gjernes E; Ben-Othman N; Vieira A; Druelle N; Faurite B; Collombat P
    Curr Top Dev Biol; 2013; 106():217-38. PubMed ID: 24290351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. β-cell replenishment: Possible curative approaches for diabetes mellitus.
    Rathwa N; Patel R; Palit SP; Parmar N; Rana S; Ansari MI; Ramachandran AV; Begum R
    Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):1870-1881. PubMed ID: 32994121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus.
    Limbert C; Päth G; Jakob F; Seufert J
    Diabetes Res Clin Pract; 2008 Mar; 79(3):389-99. PubMed ID: 17854943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cell applications in diabetes.
    Noguchi H
    J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
    Domouky AM; Hegab AS; Al-Shahat A; Raafat N
    Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133.
    Liu YA; Jin Q; Zou Y; Ding Q; Yan S; Wang Z; Hao X; Nguyen B; Zhang X; Pan J; Mo T; Jacobsen K; Lam T; Wu TY; Petrassi HM; Bursulaya B; DiDonato M; Gordon WP; Liu B; Baaten J; Hill R; Nguyen-Tran V; Qiu M; Zhang YQ; Kamireddy A; Espinola S; Deaton L; Ha S; Harb G; Jia Y; Li J; Shen W; Schumacher AM; Colman K; Glynne R; Pan S; McNamara P; Laffitte B; Meeusen S; Molteni V; Loren J
    J Med Chem; 2020 Mar; 63(6):2958-2973. PubMed ID: 32077280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta cell regeneration in human pancreas.
    Gianani R
    Semin Immunopathol; 2011 Jan; 33(1):23-7. PubMed ID: 21188381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of spontaneous regeneration of endogenous pancreatic β-cells after chemical-induced diabetes and no effect of GABA on α-to-β cell transdifferentiation in rhesus monkeys.
    Shin JS; Kim JM; Min BH; Chung H; Park CG
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1056-1061. PubMed ID: 30553443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An arduous journey from human pluripotent stem cells to functional pancreatic β cells.
    Loo LSW; Lau HH; Jasmen JB; Lim CS; Teo AKK
    Diabetes Obes Metab; 2018 Jan; 20(1):3-13. PubMed ID: 28474496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Approaches for the cure of type 1 diabetes by cellular and gene therapy.
    Jun HS; Yoon JW
    Curr Gene Ther; 2005 Apr; 5(2):249-62. PubMed ID: 15853732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
    Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
    J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CC-401 Promotes β-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition.
    Abdolazimi Y; Zhao Z; Lee S; Xu H; Allegretti P; Horton TM; Yeh B; Moeller HP; Nichols RJ; McCutcheon D; Shalizi A; Smith M; Armstrong NA; Annes JP
    Endocrinology; 2018 Sep; 159(9):3143-3157. PubMed ID: 29514186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel role of curcumin combined with bone marrow transplantation in reversing experimental diabetes: Effects on pancreatic islet regeneration, oxidative stress, and inflammatory cytokines.
    El-Azab MF; Attia FM; El-Mowafy AM
    Eur J Pharmacol; 2011 May; 658(1):41-8. PubMed ID: 21349269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From Beta cell replacement to beta cell regeneration: implications for antidiabetic therapy.
    Liu C; Wu H
    J Diabetes Sci Technol; 2014 Nov; 8(6):1221-6. PubMed ID: 25355714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-cell regeneration in human pancreas: the lessons of pancreatic pathology.
    Maulis M; Gianani R
    Adv Exp Med Biol; 2012; 771():310-8. PubMed ID: 23393687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of stem cells for pancreatic regeneration in diabetes mellitus.
    Bouwens L; Houbracken I; Mfopou JK
    Nat Rev Endocrinol; 2013 Oct; 9(10):598-606. PubMed ID: 23877422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A natural DYRK1A inhibitor as a potential stimulator for β-cell proliferation in diabetes.
    Zheng M; Zhang Q; Zhang C; Wu C; Yang K; Song Z; Wang Q; Li C; Zhou Y; Chen J; Li H; Chen L
    Clin Transl Med; 2021 Jul; 11(7):e494. PubMed ID: 34323401
    [No Abstract]   [Full Text] [Related]  

  • 39. Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes.
    Triolo TM; Bellin MD
    Front Endocrinol (Lausanne); 2021; 12():636824. PubMed ID: 33776933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation.
    Kumar K; Wang P; Sanchez R; Swartz EA; Stewart AF; DeVita RJ
    J Med Chem; 2018 Sep; 61(17):7687-7699. PubMed ID: 30059217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.